Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2022-01-10 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a confirmation certificate addressed to the company secretary of Laurus Labs Limited, referencing Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. It confirms that no securities were received for dematerialisation during the quarter ended December 2021. The document is short (1709 characters) and serves as a regulatory compliance confirmation rather than a financial report or announcement of a report. It does not contain financial data, management discussion, or voting results. It is primarily a regulatory filing confirming compliance with a specific regulation.
2022-01-10 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text contains only placeholders for images and no substantive text or financial data. The true document length is only 112 characters, indicating it is extremely short and does not contain any report content. There is no indication of any report, announcement, or filing type. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2021-12-30 English
Allotment of Securities
Regulatory Filings
2021-12-20 English
Acquisition
Regulatory Filings Classification · 95% confidence The document is extremely short (401 characters) and contains only addresses to stock exchanges with company codes, without any substantive content or financial data. There is no indication of a full report, financial statements, or detailed disclosures. It appears to be a brief communication or notice rather than a full filing. Given the brevity and lack of detail, this fits the pattern of a Regulatory Filing (RNS) as a fallback category for miscellaneous or minimal filings that do not fit other categories.
2021-12-09 English
Related Party Transactions
Regulatory Filings
2021-11-19 English
Press Release
Regulatory Filings
2021-11-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.